0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global NAD+ Anti-Aging Nutraceuticals Market Outlook, In‑Depth Analysis & Forecast to 2031
Published Date: November 2025
|
Report Code: QYRE-Auto-3D17361
Home | Market Reports | Health| Nutrition| Vitamins & Supplements
Global NAD Anti Aging Nutraceuticals Market Research Report 2024
BUY CHAPTERS

Global NAD+ Anti-Aging Nutraceuticals Market Outlook, In‑Depth Analysis & Forecast to 2031

Code: QYRE-Auto-3D17361
Report
November 2025
Pages:209
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

NAD+ Anti-Aging Nutraceuticals Market

The global NAD+ Anti-Aging Nutraceuticals market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
NAD+ Anti-Aging Nutraceuticals refer to a type of skin care or health care products containing NAD+ (nicotinamide adenine dinucleotide). In the field of anti-aging, NAD+ is considered to have the potential to delay aging, improve cell function and promote health.
NAD+, as a key molecule with "reversal power" against cellular aging, has achieved remarkable results in scientific experiments. Since the first discovery of NAD+ in 1934, scientific research has shown that it directly and indirectly affects hundreds of important metabolic enzymes in the human body, covering metabolic pathways, DNA repair, chromatin remodeling, cell aging and immune cell function. However, as we age, NAD+ levels in human tissues and cells gradually decrease. Scientists from the National Anti-Aging Research Center in the United States have discovered that supplementing NAD+ through the human body can ultimately extend lifespan and improve overall health through mitochondria and DNA repair mechanisms.
Therefore, increasing NAD+ levels has become a consensus on the road to anti-aging. However, due to the large molecular weight of NAD+, it will be decomposed in the gastrointestinal tract after oral ingestion and cannot be directly absorbed by the human body. To solve this problem, a roundabout way of taking supplements has emerged as a solution - taking the NAD+ precursor orally, which is absorbed into the bloodstream, then enters the cells and is converted into NAD+. Among the precursors of NAD+, NMN is considered to be the most effective precursor for supplementing NAD+. Other precursors either have more side effects and cause damage to human health, or are restricted by rate-limiting enzymes and have poor supplementation effects.

Report Includes:

This definitive report equips CEOs, marketing directors, and investors with a 360° view of the global NAD+ Anti-Aging Nutraceuticals market, seamlessly integrating production and sales performance across the value chain. It analyzes historical sales volume and revenue sales data (2020–2024) and delivers forecasts through 2031, illuminating demand trends and growth drivers.
By segmenting the market by Type and by Application, the study quantifies volume and value, growth rates, technical innovations, niche opportunities, and substitution risks, and analyzes downstream customers distribution pattern.
Granular regional insights cover five major markets—North America, Europe, APAC, South America, and MEA—with in‑depth analysis of 20+ countries. Each region’s dominant products, competitive landscape, and downstream demand trends are clearly detailed.
Critical competitive intelligence profiles manufacturers—sales volume, revenue, margins, pricing strategies, and major customers—and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.
A concise supply‑chain overview maps upstream suppliers, manufacturing technologies, cost structures, and distribution dynamics to identify strategic gaps and unmet demand.
Market Segmentation

Scope of NAD+ Anti-Aging Nutraceuticals Market Report

Report Metric Details
Report Name NAD+ Anti-Aging Nutraceuticals Market
Segment by Type
  • Capsules
  • Lozenges
  • Sprays
  • Others
Segment by Application
  • Health Products
  • Cosmetic
  • Others
Sales by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Swisse, Chromadex, Life Extension, Actual Anti Aging, Leading Edge Health, Swanson Health Products, High Performance Nutrition, ProHealth, BioTech Life Sciences, Genex Formulas, Renue by Science, LifeVantage, Elysium Health, Quicksilver Scientific, partiQlar, BulkSupplements, Doctor's Best, Thrivous, Cymbiotika, Avior Nutritionals, Mibelle Biochemistry, Aramore, Codeage, PrimoNutra, Neurogan Health, NUNMN, Aurora Nutrascience, Nadia Skincare, IVY RX, Emrald Labs
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Defines the NAD+ Anti-Aging Nutraceuticals study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential.
  • Chapter 2: Offers current market state, projects global revenue and sales to 2031, pinpointing high consumption regions and emerging market catalysts
  • Chapter 3: Dissects the manufacturer landscape—ranks by volume and revenue, analyzes profitability and pricing, maps production bases, details manufacturer performance by product type and evaluates concentration alongside M&A moves.
  • Chapter 4: Unlocks high margin product segments—compares sales, revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks
  • Chapter 5: Targets downstream market opportunities—evaluates sales, revenue, and pricing by Application, identifies emerging use cases, and profiles leading customers by region and by Application.
  • Chapter 6: North America—breaks down sales and revenue by Type, by Application and country, profiles key manufacturers and assesses growth drivers and barriers.
  • Chapter 7: Europe—analyses regional sales, revenue and market by Type, by Application and manufacturers, flagging drivers and barriers.
  • Chapter 8: Asia Pacific—quantifies sales and revenue by Type, by Application, and region/country, profiles top manufacturers, and uncovers high potential expansion areas.
  • Chapter 9: Central & South America—measures sales and revenue by Type, by Application, and country, profiles top manufacturers, and identifies investment opportunities and challenges.
  • Chapter 10: Middle East and Africa—evaluates sales and revenue by Type, by Application, and country, profiles key manufacturers, and outlines investment prospects and market hurdles
  • Chapter 11: Profiles manufacturers in depth—details product specs, sales, revenue, margins; Top manufactures 2024 sales breakdowns by Product type, by Application, by sales region SWOT analysis, and recent strategic developments.
  • Chapter 12: Supply chain—analyses upstream raw materials and suppliers, manufacturing footprint, regional production and cost, regulatory and technology, plus downstream channels and distributor roles.
  • Chapter 13: Market dynamics—explores drivers, restraints, regulatory impacts, and risk mitigation strategies.
  • Chapter 15: Actionable conclusions and strategic recommendations.
  • Why This Report:
  • Beyond standard market data, this analysis provides a clear profitability roadmap—empowering you to:
  • Allocate capital strategically to high growth regions (Chapters 6–10) and margin rich segments (Chapter 5).
  • Negotiate from strength with suppliers (Chapter 12) and customers (Chapter5) using cost and demand intelligence.
  • Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 3 and 11).
  • Secure your supply chain against disruptions through upstream and downstream visibility (Chapters 12 and 13).
  • Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.

FAQ for this report

Who are the main players in the NAD+ Anti-Aging Nutraceuticals Market report?

Ans: The main players in the NAD+ Anti-Aging Nutraceuticals Market are Swisse, Chromadex, Life Extension, Actual Anti Aging, Leading Edge Health, Swanson Health Products, High Performance Nutrition, ProHealth, BioTech Life Sciences, Genex Formulas, Renue by Science, LifeVantage, Elysium Health, Quicksilver Scientific, partiQlar, BulkSupplements, Doctor's Best, Thrivous, Cymbiotika, Avior Nutritionals, Mibelle Biochemistry, Aramore, Codeage, PrimoNutra, Neurogan Health, NUNMN, Aurora Nutrascience, Nadia Skincare, IVY RX, Emrald Labs

What are the Application segmentation covered in the NAD+ Anti-Aging Nutraceuticals Market report?

Ans: The Applications covered in the NAD+ Anti-Aging Nutraceuticals Market report are Health Products, Cosmetic, Others

What are the Type segmentation covered in the NAD+ Anti-Aging Nutraceuticals Market report?

Ans: The Types covered in the NAD+ Anti-Aging Nutraceuticals Market report are Capsules, Lozenges, Sprays, Others

1 Study Coverage
1.1 Introduction to NAD+ Anti-Aging Nutraceuticals: Definition, Properties, and Key Attributes
1.2 Market Segmentation by Type
1.2.1 Global NAD+ Anti-Aging Nutraceuticals Market Size by Type, 2020 VS 2024 VS 2031
1.2.2 Capsules
1.2.3 Lozenges
1.2.4 Sprays
1.2.5 Others
1.3 Market Segmentation by Application
1.3.1 Global NAD+ Anti-Aging Nutraceuticals Market Size by Application, 2020 VS 2024 VS 2031
1.3.2 Health Products
1.3.3 Cosmetic
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global NAD+ Anti-Aging Nutraceuticals Revenue Estimates and Forecasts 2020-2031
2.2 Global NAD+ Anti-Aging Nutraceuticals Revenue by Region
2.2.1 Revenue Comparison: 2020 VS 2024 VS 2031
2.2.2 Historical and Forecasted Revenue by Region (2020--2031)
2.2.3 Global Revenue Market Share by Region (2020-2031)
2.3 Global NAD+ Anti-Aging Nutraceuticals Sales Estimates and Forecasts 2020-2031
2.4 Global NAD+ Anti-Aging Nutraceuticals Sales by Region
2.4.1 Sales Comparison: 2020 VS 2024 VS 2031
2.4.2 Historical and Forecasted Sales by Region (2020-2031)
2.4.3 Emerging Market Focus: Growth Drivers & Investment Trends
2.4.4 Global Sales Market Share by Region (2020-2031)
3 Competition by Manufacturers
3.1 Global NAD+ Anti-Aging Nutraceuticals Sales by Manufacturers
3.1.1 Global Sales Volume by Manufacturers (2020-2025)
3.1.2 Global Top 5 and Top 10 Manufacturers’Market Share by Sales Volume (2024)
3.2 Global NAD+ Anti-Aging Nutraceuticals Manufacturer Revenue Rankings and Tiers
3.2.1 Global Revenue (Value) by Manufacturers (2020-2025)
3.2.2 Global Key Manufacturer Revenue Ranking (2023 vs. 2024)
3.2.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)
3.3 Manufacturer Profitability Profiles and Pricing Strategies
3.3.1 Gross Margin by Top Manufacturer (2020 VS 2024)
3.3.2 Manufacturer-Level Price Trends (2020-2025)
3.4 Key Manufacturers Manufacturing Base and Headquarters
3.5 Main Product Type Market Size by Manufacturers
3.5.1 Capsules Market Size by Manufacturers
3.5.2 Lozenges Market Size by Manufacturers
3.5.3 Sprays Market Size by Manufacturers
3.5.4 Others Market Size by Manufacturers
3.6 Global NAD+ Anti-Aging Nutraceuticals Market Concentration and Dynamics
3.6.1 Global Market Concentration (CR5 and HHI)
3.6.2 Entrant/Exit Impact Analysis
3.6.3 Strategic Moves: M&A, Capacity Expansion, R&D Investment
4 Global Product Segmentation Analysis
4.1 Global NAD+ Anti-Aging Nutraceuticals Sales Performance by Type
4.1.1 Global Historical and Forecasted Sales by Type (2020-2031)
4.1.2 Global Sales Market Share by Type (2020-2031)
4.2 Global NAD+ Anti-Aging Nutraceuticals Revenue Trends by Type
4.2.1 Global Historical and Forecasted Revenue by Type (2020-2031)
4.2.2 Global Revenue Market Share by Type (2020-2031)
4.3 Global Average Selling Price (ASP) Trends by Type (2020-2031)
4.4 Product Technology Differentiation
4.5 Subtype Dynamics: Growth Leaders, Profitability and Risk
4.5.1 High-Growth Niches and Adoption Drivers
4.5.2 Profitability Hotspots and Cost Drivers
4.5.3 Substitution Threats
5 Global Downstream Application Analysis
5.1 Global NAD+ Anti-Aging Nutraceuticals Sales by Application
5.1.1 Global Historical and Forecasted Sales by Application (2020-2031)
5.1.2 Global Sales Market Share by Application (2020-2031)
5.1.3 High-Growth Application Identification
5.1.4 Emerging Application Case Studies
5.2 Global NAD+ Anti-Aging Nutraceuticals Revenue by Application
5.2.1 Global Historical and Forecasted Revenue by Application (2020-2031)
5.2.2 Revenue Market Share by Application (2020-2031)
5.3 Global Pricing Dynamics by Application (2020-2031)
5.4 Downstream Customer Analysis
5.4.1 Top Customers by Region
5.4.2 Top Customers by Application
6 North America
6.1 North America Sales Volume and Revenue (2020-2031)
6.2 North America Key Manufacturers Sales Revenue in 2024
6.3 North America NAD+ Anti-Aging Nutraceuticals Sales and Revenue by Type (2020-2031)
6.4 North America NAD+ Anti-Aging Nutraceuticals Sales and Revenue by Application (2020-2031)
6.5 North America Growth Accelerators and Market Barriers
6.6 North America NAD+ Anti-Aging Nutraceuticals Market Size by Country
6.6.1 North America Revenue by Country
6.6.2 North America Sales Trends by Country
6.6.3 US
6.6.4 Canada
6.6.5 Mexico
7 Europe
7.1 Europe Sales Volume and Revenue (2020-2031)
7.2 Europe Key Manufacturers Sales Revenue in 2024
7.3 Europe NAD+ Anti-Aging Nutraceuticals Sales and Revenue by Type (2020-2031)
7.4 Europe NAD+ Anti-Aging Nutraceuticals Sales and Revenue by Application (2020-2031)
7.5 Europe Growth Accelerators and Market Barriers
7.6 Europe NAD+ Anti-Aging Nutraceuticals Market Size by Country
7.6.1 Europe Revenue by Country
7.6.2 Europe Sales Trends by Country
7.6.3 Germany
7.6.4 France
7.6.5 U.K.
7.6.6 Italy
7.6.7 Russia
8 Asia-Pacific
8.1 Asia-Pacific Sales Volume and Revenue (2020-2031)
8.2 Asia-Pacific Key Manufacturers Sales Revenue in 2024
8.3 Asia-Pacific NAD+ Anti-Aging Nutraceuticals Sales and Revenue by Type (2020-2031)
8.4 Asia-Pacific NAD+ Anti-Aging Nutraceuticals Sales and Revenue by Application (2020-2031)
8.5 Asia-Pacific NAD+ Anti-Aging Nutraceuticals Market Size by Region
8.5.1 Asia-Pacific Revenue by Region
8.5.2 Asia-Pacific Sales Trends by Region
8.6 Asia-Pacific Growth Accelerators and Market Barriers
8.7 Southeast Asia
8.7.1 Southeast Asia Revenue by Country (2020 VS 2024 VS 2031)
8.7.2 Key Country Analysis: Indonesia, Vietnam, Thailand, Malaysia, Philippines
8.8 China
8.9 Japan
8.10 South Korea
8.11 China Taiwan
8.12 India
9 Central and South America
9.1 Central and South America Sales Volume and Revenue (2020-2031)
9.2 Central and South America Key Manufacturers Sales Revenue in 2024
9.3 Central and South America NAD+ Anti-Aging Nutraceuticals Sales and Revenue by Type (2020-2031)
9.4 Central and South America NAD+ Anti-Aging Nutraceuticals Sales and Revenue by Application (2020-2031)
9.5 Central and South America Investment Opportunities and Key Challenges
9.6 Central and South America NAD+ Anti-Aging Nutraceuticals Market Size by Country
9.6.1 Central and South America Revenue Trends by Country (2020 VS 2024 VS 2031)
9.6.2 Brazil
9.6.3 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Sales Volume and Revenue (2020-2031)
10.2 Middle East and Africa Key Manufacturers Sales Revenue in 2024
10.3 Middle East and Africa NAD+ Anti-Aging Nutraceuticals Sales and Revenue by Type (2020-2031)
10.4 Middle East and Africa NAD+ Anti-Aging Nutraceuticals Sales and Revenue by Application (2020-2031)
10.5 Middle East and Africa Investment Opportunities and Key Challenges
10.6 Middle East and Africa NAD+ Anti-Aging Nutraceuticals Market Size by Country
10.6.1 Middle East and Africa Revenue Trends by Country (2020 VS 2024 VS 2031)
10.6.2 GCC Countries
10.6.3 Turkey
10.6.4 Egypt
10.6.5 South Africa
11 Corporate Profile
11.1 Swisse
11.1.1 Swisse Corporation Information
11.1.2 Swisse Business Overview
11.1.3 Swisse NAD+ Anti-Aging Nutraceuticals Product Models, Descriptions and Specifications
11.1.4 Swisse NAD+ Anti-Aging Nutraceuticals Sales, Price, Revenue and Gross Margin (2020-2025)
11.1.5 Swisse NAD+ Anti-Aging Nutraceuticals Sales by Product in 2024
11.1.6 Swisse NAD+ Anti-Aging Nutraceuticals Sales by Application in 2024
11.1.7 Swisse NAD+ Anti-Aging Nutraceuticals Sales by Geographic Area in 2024
11.1.8 Swisse NAD+ Anti-Aging Nutraceuticals SWOT Analysis
11.1.9 Swisse Recent Developments
11.2 Chromadex
11.2.1 Chromadex Corporation Information
11.2.2 Chromadex Business Overview
11.2.3 Chromadex NAD+ Anti-Aging Nutraceuticals Product Models, Descriptions and Specifications
11.2.4 Chromadex NAD+ Anti-Aging Nutraceuticals Sales, Price, Revenue and Gross Margin (2020-2025)
11.2.5 Chromadex NAD+ Anti-Aging Nutraceuticals Sales by Product in 2024
11.2.6 Chromadex NAD+ Anti-Aging Nutraceuticals Sales by Application in 2024
11.2.7 Chromadex NAD+ Anti-Aging Nutraceuticals Sales by Geographic Area in 2024
11.2.8 Chromadex NAD+ Anti-Aging Nutraceuticals SWOT Analysis
11.2.9 Chromadex Recent Developments
11.3 Life Extension
11.3.1 Life Extension Corporation Information
11.3.2 Life Extension Business Overview
11.3.3 Life Extension NAD+ Anti-Aging Nutraceuticals Product Models, Descriptions and Specifications
11.3.4 Life Extension NAD+ Anti-Aging Nutraceuticals Sales, Price, Revenue and Gross Margin (2020-2025)
11.3.5 Life Extension NAD+ Anti-Aging Nutraceuticals Sales by Product in 2024
11.3.6 Life Extension NAD+ Anti-Aging Nutraceuticals Sales by Application in 2024
11.3.7 Life Extension NAD+ Anti-Aging Nutraceuticals Sales by Geographic Area in 2024
11.3.8 Life Extension NAD+ Anti-Aging Nutraceuticals SWOT Analysis
11.3.9 Life Extension Recent Developments
11.4 Actual Anti Aging
11.4.1 Actual Anti Aging Corporation Information
11.4.2 Actual Anti Aging Business Overview
11.4.3 Actual Anti Aging NAD+ Anti-Aging Nutraceuticals Product Models, Descriptions and Specifications
11.4.4 Actual Anti Aging NAD+ Anti-Aging Nutraceuticals Sales, Price, Revenue and Gross Margin (2020-2025)
11.4.5 Actual Anti Aging NAD+ Anti-Aging Nutraceuticals Sales by Product in 2024
11.4.6 Actual Anti Aging NAD+ Anti-Aging Nutraceuticals Sales by Application in 2024
11.4.7 Actual Anti Aging NAD+ Anti-Aging Nutraceuticals Sales by Geographic Area in 2024
11.4.8 Actual Anti Aging NAD+ Anti-Aging Nutraceuticals SWOT Analysis
11.4.9 Actual Anti Aging Recent Developments
11.5 Leading Edge Health
11.5.1 Leading Edge Health Corporation Information
11.5.2 Leading Edge Health Business Overview
11.5.3 Leading Edge Health NAD+ Anti-Aging Nutraceuticals Product Models, Descriptions and Specifications
11.5.4 Leading Edge Health NAD+ Anti-Aging Nutraceuticals Sales, Price, Revenue and Gross Margin (2020-2025)
11.5.5 Leading Edge Health NAD+ Anti-Aging Nutraceuticals Sales by Product in 2024
11.5.6 Leading Edge Health NAD+ Anti-Aging Nutraceuticals Sales by Application in 2024
11.5.7 Leading Edge Health NAD+ Anti-Aging Nutraceuticals Sales by Geographic Area in 2024
11.5.8 Leading Edge Health NAD+ Anti-Aging Nutraceuticals SWOT Analysis
11.5.9 Leading Edge Health Recent Developments
11.6 Swanson Health Products
11.6.1 Swanson Health Products Corporation Information
11.6.2 Swanson Health Products Business Overview
11.6.3 Swanson Health Products NAD+ Anti-Aging Nutraceuticals Product Models, Descriptions and Specifications
11.6.4 Swanson Health Products NAD+ Anti-Aging Nutraceuticals Sales, Price, Revenue and Gross Margin (2020-2025)
11.6.5 Swanson Health Products Recent Developments
11.7 High Performance Nutrition
11.7.1 High Performance Nutrition Corporation Information
11.7.2 High Performance Nutrition Business Overview
11.7.3 High Performance Nutrition NAD+ Anti-Aging Nutraceuticals Product Models, Descriptions and Specifications
11.7.4 High Performance Nutrition NAD+ Anti-Aging Nutraceuticals Sales, Price, Revenue and Gross Margin (2020-2025)
11.7.5 High Performance Nutrition Recent Developments
11.8 ProHealth
11.8.1 ProHealth Corporation Information
11.8.2 ProHealth Business Overview
11.8.3 ProHealth NAD+ Anti-Aging Nutraceuticals Product Models, Descriptions and Specifications
11.8.4 ProHealth NAD+ Anti-Aging Nutraceuticals Sales, Price, Revenue and Gross Margin (2020-2025)
11.8.5 ProHealth Recent Developments
11.9 BioTech Life Sciences
11.9.1 BioTech Life Sciences Corporation Information
11.9.2 BioTech Life Sciences Business Overview
11.9.3 BioTech Life Sciences NAD+ Anti-Aging Nutraceuticals Product Models, Descriptions and Specifications
11.9.4 BioTech Life Sciences NAD+ Anti-Aging Nutraceuticals Sales, Price, Revenue and Gross Margin (2020-2025)
11.9.5 BioTech Life Sciences Recent Developments
11.10 Genex Formulas
11.10.1 Genex Formulas Corporation Information
11.10.2 Genex Formulas Business Overview
11.10.3 Genex Formulas NAD+ Anti-Aging Nutraceuticals Product Models, Descriptions and Specifications
11.10.4 Genex Formulas NAD+ Anti-Aging Nutraceuticals Sales, Price, Revenue and Gross Margin (2020-2025)
11.10.5 Genex Formulas Recent Developments
11.11 Renue by Science
11.11.1 Renue by Science Corporation Information
11.11.2 Renue by Science Business Overview
11.11.3 Renue by Science NAD+ Anti-Aging Nutraceuticals Product Models, Descriptions and Specifications
11.11.4 Renue by Science NAD+ Anti-Aging Nutraceuticals Sales, Price, Revenue and Gross Margin (2020-2025)
11.11.5 Renue by Science Recent Developments
11.12 LifeVantage
11.12.1 LifeVantage Corporation Information
11.12.2 LifeVantage Business Overview
11.12.3 LifeVantage NAD+ Anti-Aging Nutraceuticals Product Models, Descriptions and Specifications
11.12.4 LifeVantage NAD+ Anti-Aging Nutraceuticals Sales, Price, Revenue and Gross Margin (2020-2025)
11.12.5 LifeVantage Recent Developments
11.13 Elysium Health
11.13.1 Elysium Health Corporation Information
11.13.2 Elysium Health Business Overview
11.13.3 Elysium Health NAD+ Anti-Aging Nutraceuticals Product Models, Descriptions and Specifications
11.13.4 Elysium Health NAD+ Anti-Aging Nutraceuticals Sales, Price, Revenue and Gross Margin (2020-2025)
11.13.5 Elysium Health Recent Developments
11.14 Quicksilver Scientific
11.14.1 Quicksilver Scientific Corporation Information
11.14.2 Quicksilver Scientific Business Overview
11.14.3 Quicksilver Scientific NAD+ Anti-Aging Nutraceuticals Product Models, Descriptions and Specifications
11.14.4 Quicksilver Scientific NAD+ Anti-Aging Nutraceuticals Sales, Price, Revenue and Gross Margin (2020-2025)
11.14.5 Quicksilver Scientific Recent Developments
11.15 partiQlar
11.15.1 partiQlar Corporation Information
11.15.2 partiQlar Business Overview
11.15.3 partiQlar NAD+ Anti-Aging Nutraceuticals Product Models, Descriptions and Specifications
11.15.4 partiQlar NAD+ Anti-Aging Nutraceuticals Sales, Price, Revenue and Gross Margin (2020-2025)
11.15.5 partiQlar Recent Developments
11.16 BulkSupplements
11.16.1 BulkSupplements Corporation Information
11.16.2 BulkSupplements Business Overview
11.16.3 BulkSupplements NAD+ Anti-Aging Nutraceuticals Product Models, Descriptions and Specifications
11.16.4 BulkSupplements NAD+ Anti-Aging Nutraceuticals Sales, Price, Revenue and Gross Margin (2020-2025)
11.16.5 BulkSupplements Recent Developments
11.17 Doctor's Best
11.17.1 Doctor's Best Corporation Information
11.17.2 Doctor's Best Business Overview
11.17.3 Doctor's Best NAD+ Anti-Aging Nutraceuticals Product Models, Descriptions and Specifications
11.17.4 Doctor's Best NAD+ Anti-Aging Nutraceuticals Sales, Price, Revenue and Gross Margin (2020-2025)
11.17.5 Doctor's Best Recent Developments
11.18 Thrivous
11.18.1 Thrivous Corporation Information
11.18.2 Thrivous Business Overview
11.18.3 Thrivous NAD+ Anti-Aging Nutraceuticals Product Models, Descriptions and Specifications
11.18.4 Thrivous NAD+ Anti-Aging Nutraceuticals Sales, Price, Revenue and Gross Margin (2020-2025)
11.18.5 Thrivous Recent Developments
11.19 Cymbiotika
11.19.1 Cymbiotika Corporation Information
11.19.2 Cymbiotika Business Overview
11.19.3 Cymbiotika NAD+ Anti-Aging Nutraceuticals Product Models, Descriptions and Specifications
11.19.4 Cymbiotika NAD+ Anti-Aging Nutraceuticals Sales, Price, Revenue and Gross Margin (2020-2025)
11.19.5 Cymbiotika Recent Developments
11.20 Avior Nutritionals
11.20.1 Avior Nutritionals Corporation Information
11.20.2 Avior Nutritionals Business Overview
11.20.3 Avior Nutritionals NAD+ Anti-Aging Nutraceuticals Product Models, Descriptions and Specifications
11.20.4 Avior Nutritionals NAD+ Anti-Aging Nutraceuticals Sales, Price, Revenue and Gross Margin (2020-2025)
11.20.5 Avior Nutritionals Recent Developments
11.21 Mibelle Biochemistry
11.21.1 Mibelle Biochemistry Corporation Information
11.21.2 Mibelle Biochemistry Business Overview
11.21.3 Mibelle Biochemistry NAD+ Anti-Aging Nutraceuticals Product Models, Descriptions and Specifications
11.21.4 Mibelle Biochemistry NAD+ Anti-Aging Nutraceuticals Sales, Price, Revenue and Gross Margin (2020-2025)
11.21.5 Mibelle Biochemistry Recent Developments
11.22 Aramore
11.22.1 Aramore Corporation Information
11.22.2 Aramore Business Overview
11.22.3 Aramore NAD+ Anti-Aging Nutraceuticals Product Models, Descriptions and Specifications
11.22.4 Aramore NAD+ Anti-Aging Nutraceuticals Sales, Price, Revenue and Gross Margin (2020-2025)
11.22.5 Aramore Recent Developments
11.23 Codeage
11.23.1 Codeage Corporation Information
11.23.2 Codeage Business Overview
11.23.3 Codeage NAD+ Anti-Aging Nutraceuticals Product Models, Descriptions and Specifications
11.23.4 Codeage NAD+ Anti-Aging Nutraceuticals Sales, Price, Revenue and Gross Margin (2020-2025)
11.23.5 Codeage Recent Developments
11.24 PrimoNutra
11.24.1 PrimoNutra Corporation Information
11.24.2 PrimoNutra Business Overview
11.24.3 PrimoNutra NAD+ Anti-Aging Nutraceuticals Product Models, Descriptions and Specifications
11.24.4 PrimoNutra NAD+ Anti-Aging Nutraceuticals Sales, Price, Revenue and Gross Margin (2020-2025)
11.24.5 PrimoNutra Recent Developments
11.25 Neurogan Health
11.25.1 Neurogan Health Corporation Information
11.25.2 Neurogan Health Business Overview
11.25.3 Neurogan Health NAD+ Anti-Aging Nutraceuticals Product Models, Descriptions and Specifications
11.25.4 Neurogan Health NAD+ Anti-Aging Nutraceuticals Sales, Price, Revenue and Gross Margin (2020-2025)
11.25.5 Neurogan Health Recent Developments
11.26 NUNMN
11.26.1 NUNMN Corporation Information
11.26.2 NUNMN Business Overview
11.26.3 NUNMN NAD+ Anti-Aging Nutraceuticals Product Models, Descriptions and Specifications
11.26.4 NUNMN NAD+ Anti-Aging Nutraceuticals Sales, Price, Revenue and Gross Margin (2020-2025)
11.26.5 NUNMN Recent Developments
11.27 Aurora Nutrascience
11.27.1 Aurora Nutrascience Corporation Information
11.27.2 Aurora Nutrascience Business Overview
11.27.3 Aurora Nutrascience NAD+ Anti-Aging Nutraceuticals Product Models, Descriptions and Specifications
11.27.4 Aurora Nutrascience NAD+ Anti-Aging Nutraceuticals Sales, Price, Revenue and Gross Margin (2020-2025)
11.27.5 Aurora Nutrascience Recent Developments
11.28 Nadia Skincare
11.28.1 Nadia Skincare Corporation Information
11.28.2 Nadia Skincare Business Overview
11.28.3 Nadia Skincare NAD+ Anti-Aging Nutraceuticals Product Models, Descriptions and Specifications
11.28.4 Nadia Skincare NAD+ Anti-Aging Nutraceuticals Sales, Price, Revenue and Gross Margin (2020-2025)
11.28.5 Nadia Skincare Recent Developments
11.29 IVY RX
11.29.1 IVY RX Corporation Information
11.29.2 IVY RX Business Overview
11.29.3 IVY RX NAD+ Anti-Aging Nutraceuticals Product Models, Descriptions and Specifications
11.29.4 IVY RX NAD+ Anti-Aging Nutraceuticals Sales, Price, Revenue and Gross Margin (2020-2025)
11.29.5 IVY RX Recent Developments
11.30 Emrald Labs
11.30.1 Emrald Labs Corporation Information
11.30.2 Emrald Labs Business Overview
11.30.3 Emrald Labs NAD+ Anti-Aging Nutraceuticals Product Models, Descriptions and Specifications
11.30.4 Emrald Labs NAD+ Anti-Aging Nutraceuticals Sales, Price, Revenue and Gross Margin (2020-2025)
11.30.5 Emrald Labs Recent Developments
12 Value Chain and Supply-Chain Analysis
12.1 NAD+ Anti-Aging Nutraceuticals Industry Chain
12.2 NAD+ Anti-Aging Nutraceuticals Upstream Materials Analysis
12.2.1 Raw Materials
12.2.2 Key Suppliers Market Share & Risk Assessment
12.3 NAD+ Anti-Aging Nutraceuticals Integrated Production Analysis
12.3.1 Manufacturing Footprint Analysis
12.3.2 Regional Production Market Share (2020-2031)
12.3.3 Regulatory and Trade Policy Impact on Production
12.3.4 Production Technology Overview
12.3.5 Regional Cost Drivers
12.4 NAD+ Anti-Aging Nutraceuticals Sales Channels and Distribution Networks
12.4.1 Sales Channels
12.4.2 Distributors
13 NAD+ Anti-Aging Nutraceuticals Market Dynamics
13.1 Industry Trends and Evolution
13.2 Market Growth Drivers and Emerging Opportunities
13.3 Market Challenges, Risks, and Restraints
14 Key Findings in the Global NAD+ Anti-Aging Nutraceuticals Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details
List of Tables
 Table 1. Global NAD+ Anti-Aging Nutraceuticals Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
 Table 2. Global NAD+ Anti-Aging Nutraceuticals Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
 Table 3. Global NAD+ Anti-Aging Nutraceuticals Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 4. Global NAD+ Anti-Aging Nutraceuticals Revenue by Region (2020-2025) & (US$ Million)
 Table 5. Global NAD+ Anti-Aging Nutraceuticals Revenue by Region (2026-2031) & (US$ Million)
 Table 6. Global NAD+ Anti-Aging Nutraceuticals Sales Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (K Units)
 Table 7. Global NAD+ Anti-Aging Nutraceuticals Sales by Region (2020-2025) & (K Units)
 Table 8. Global NAD+ Anti-Aging Nutraceuticals Sales by Region (2026-2031) & (K Units)
 Table 9. Emerging Market Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 10. Global NAD+ Anti-Aging Nutraceuticals Sales by Manufacturers (2020-2025) & (K Units)
 Table 11. Global NAD+ Anti-Aging Nutraceuticals Sales Share by Manufacturers (2020-2025)
 Table 12. Global NAD+ Anti-Aging Nutraceuticals Revenue by Manufacturers (2020-2025) & (US$ Million)
 Table 13. Global NAD+ Anti-Aging Nutraceuticals Revenue Market Share by Manufacturers (2020-2025)
 Table 14. Global Key Manufacturers’Ranking Shift (2023 vs. 2024) (Based on Revenue)
 Table 15. Global NAD+ Anti-Aging Nutraceuticals by Manufacturer Tier (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in NAD+ Anti-Aging Nutraceuticals as of 2024)
 Table 16. Global NAD+ Anti-Aging Nutraceuticals Average Gross Margin (%) by Manufacturer (2020 VS 2024)
 Table 17. Global NAD+ Anti-Aging Nutraceuticals Average Selling Price (ASP) by Manufacturers (2020-2025) & (US$/Unit)
 Table 18. Key Manufacturers NAD+ Anti-Aging Nutraceuticals Manufacturing Base and Headquarters
 Table 19. Global NAD+ Anti-Aging Nutraceuticals Market Concentration Ratio (CR5 and HHI)
 Table 20. Key Market Entrant/Exit (2020-2024) – Drivers & Impact Analysis
 Table 21. Key Mergers & Acquisitions, Expansion Plans, R&D Investment
 Table 22. Global NAD+ Anti-Aging Nutraceuticals Sales by Type (2020-2025) & (K Units)
 Table 23. Global NAD+ Anti-Aging Nutraceuticals Sales by Type (2026-2031) & (K Units)
 Table 24. Global NAD+ Anti-Aging Nutraceuticals Revenue by Type (2020-2025) & (US$ Million)
 Table 25. Global NAD+ Anti-Aging Nutraceuticals Revenue by Type (2026-2031) & (US$ Million)
 Table 26. Global NAD+ Anti-Aging Nutraceuticals ASP by Type (2020-2031) & (US$/Unit)
 Table 27. Technical Specifications by Key Product Type
 Table 28. Global NAD+ Anti-Aging Nutraceuticals Sales by Application (2020-2025) & (K Units)
 Table 29. Global NAD+ Anti-Aging Nutraceuticals Sales by Application (2026-2031) & (K Units)
 Table 30. NAD+ Anti-Aging Nutraceuticals High-Growth Sectors Demand CAGR (2024-2031)
 Table 31. Global NAD+ Anti-Aging Nutraceuticals Revenue by Application (2020-2025) & (US$ Million)
 Table 32. Global NAD+ Anti-Aging Nutraceuticals Revenue by Application (2026-2031) & (US$ Million)
 Table 33. Global NAD+ Anti-Aging Nutraceuticals ASP by Application (2020-2031) & (US$/Unit)
 Table 34. Top Customers by Region
 Table 35. Top Customers by Application
 Table 36. North America NAD+ Anti-Aging Nutraceuticals Growth Accelerators and Market Barriers
 Table 37. North America NAD+ Anti-Aging Nutraceuticals Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 38. North America NAD+ Anti-Aging Nutraceuticals Sales (K Units) by Country (2020 VS 2024 VS 2031)
 Table 39. Europe NAD+ Anti-Aging Nutraceuticals Growth Accelerators and Market Barriers
 Table 40. Europe NAD+ Anti-Aging Nutraceuticals Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Europe NAD+ Anti-Aging Nutraceuticals Sales (K Units) by Country (2020 VS 2024 VS 2031)
 Table 42. Asia-Pacific NAD+ Anti-Aging Nutraceuticals Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 43. Asia-Pacific NAD+ Anti-Aging Nutraceuticals Sales (K Units) by Country (2020 VS 2024 VS 2031)
 Table 44. Asia-Pacific NAD+ Anti-Aging Nutraceuticals Growth Accelerators and Market Barriers
 Table 45. Southeast Asia NAD+ Anti-Aging Nutraceuticals Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Central and South America NAD+ Anti-Aging Nutraceuticals Investment Opportunities and Key Challenges
 Table 47. Central and South America NAD+ Anti-Aging Nutraceuticals Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 48. Middle East and Africa NAD+ Anti-Aging Nutraceuticals Investment Opportunities and Key Challenges
 Table 49. Middle East and Africa NAD+ Anti-Aging Nutraceuticals Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 50. Swisse Corporation Information
 Table 51. Swisse Description and Major Businesses
 Table 52. Swisse Product Models, Descriptions and Specifications
 Table 53. Swisse Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 54. Swisse Sales Value Proportion by Product in 2024
 Table 55. Swisse Sales Value Proportion by Application in 2024
 Table 56. Swisse Sales Value Proportion by Geographic Area in 2024
 Table 57. Swisse NAD+ Anti-Aging Nutraceuticals SWOT Analysis
 Table 58. Swisse Recent Developments
 Table 59. Chromadex Corporation Information
 Table 60. Chromadex Description and Major Businesses
 Table 61. Chromadex Product Models, Descriptions and Specifications
 Table 62. Chromadex Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 63. Chromadex Sales Value Proportion by Product in 2024
 Table 64. Chromadex Sales Value Proportion by Application in 2024
 Table 65. Chromadex Sales Value Proportion by Geographic Area in 2024
 Table 66. Chromadex NAD+ Anti-Aging Nutraceuticals SWOT Analysis
 Table 67. Chromadex Recent Developments
 Table 68. Life Extension Corporation Information
 Table 69. Life Extension Description and Major Businesses
 Table 70. Life Extension Product Models, Descriptions and Specifications
 Table 71. Life Extension Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 72. Life Extension Sales Value Proportion by Product in 2024
 Table 73. Life Extension Sales Value Proportion by Application in 2024
 Table 74. Life Extension Sales Value Proportion by Geographic Area in 2024
 Table 75. Life Extension NAD+ Anti-Aging Nutraceuticals SWOT Analysis
 Table 76. Life Extension Recent Developments
 Table 77. Actual Anti Aging Corporation Information
 Table 78. Actual Anti Aging Description and Major Businesses
 Table 79. Actual Anti Aging Product Models, Descriptions and Specifications
 Table 80. Actual Anti Aging Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 81. Actual Anti Aging Sales Value Proportion by Product in 2024
 Table 82. Actual Anti Aging Sales Value Proportion by Application in 2024
 Table 83. Actual Anti Aging Sales Value Proportion by Geographic Area in 2024
 Table 84. Actual Anti Aging NAD+ Anti-Aging Nutraceuticals SWOT Analysis
 Table 85. Actual Anti Aging Recent Developments
 Table 86. Leading Edge Health Corporation Information
 Table 87. Leading Edge Health Description and Major Businesses
 Table 88. Leading Edge Health Product Models, Descriptions and Specifications
 Table 89. Leading Edge Health Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 90. Leading Edge Health Sales Value Proportion by Product in 2024
 Table 91. Leading Edge Health Sales Value Proportion by Application in 2024
 Table 92. Leading Edge Health Sales Value Proportion by Geographic Area in 2024
 Table 93. Leading Edge Health NAD+ Anti-Aging Nutraceuticals SWOT Analysis
 Table 94. Leading Edge Health Recent Developments
 Table 95. Swanson Health Products Corporation Information
 Table 96. Swanson Health Products Description and Major Businesses
 Table 97. Swanson Health Products Product Models, Descriptions and Specifications
 Table 98. Swanson Health Products Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 99. Swanson Health Products Recent Developments
 Table 100. High Performance Nutrition Corporation Information
 Table 101. High Performance Nutrition Description and Major Businesses
 Table 102. High Performance Nutrition Product Models, Descriptions and Specifications
 Table 103. High Performance Nutrition Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 104. High Performance Nutrition Recent Developments
 Table 105. ProHealth Corporation Information
 Table 106. ProHealth Description and Major Businesses
 Table 107. ProHealth Product Models, Descriptions and Specifications
 Table 108. ProHealth Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 109. ProHealth Recent Developments
 Table 110. BioTech Life Sciences Corporation Information
 Table 111. BioTech Life Sciences Description and Major Businesses
 Table 112. BioTech Life Sciences Product Models, Descriptions and Specifications
 Table 113. BioTech Life Sciences Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 114. BioTech Life Sciences Recent Developments
 Table 115. Genex Formulas Corporation Information
 Table 116. Genex Formulas Description and Major Businesses
 Table 117. Genex Formulas Product Models, Descriptions and Specifications
 Table 118. Genex Formulas Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 119. Genex Formulas Recent Developments
 Table 120. Renue by Science Corporation Information
 Table 121. Renue by Science Description and Major Businesses
 Table 122. Renue by Science Product Models, Descriptions and Specifications
 Table 123. Renue by Science Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 124. Renue by Science Recent Developments
 Table 125. LifeVantage Corporation Information
 Table 126. LifeVantage Description and Major Businesses
 Table 127. LifeVantage Product Models, Descriptions and Specifications
 Table 128. LifeVantage Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 129. LifeVantage Recent Developments
 Table 130. Elysium Health Corporation Information
 Table 131. Elysium Health Description and Major Businesses
 Table 132. Elysium Health Product Models, Descriptions and Specifications
 Table 133. Elysium Health Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 134. Elysium Health Recent Developments
 Table 135. Quicksilver Scientific Corporation Information
 Table 136. Quicksilver Scientific Description and Major Businesses
 Table 137. Quicksilver Scientific Product Models, Descriptions and Specifications
 Table 138. Quicksilver Scientific Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 139. Quicksilver Scientific Recent Developments
 Table 140. partiQlar Corporation Information
 Table 141. partiQlar Description and Major Businesses
 Table 142. partiQlar Product Models, Descriptions and Specifications
 Table 143. partiQlar Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 144. partiQlar Recent Developments
 Table 145. BulkSupplements Corporation Information
 Table 146. BulkSupplements Description and Major Businesses
 Table 147. BulkSupplements Product Models, Descriptions and Specifications
 Table 148. BulkSupplements Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 149. BulkSupplements Recent Developments
 Table 150. Doctor's Best Corporation Information
 Table 151. Doctor's Best Description and Major Businesses
 Table 152. Doctor's Best Product Models, Descriptions and Specifications
 Table 153. Doctor's Best Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 154. Doctor's Best Recent Developments
 Table 155. Thrivous Corporation Information
 Table 156. Thrivous Description and Major Businesses
 Table 157. Thrivous Product Models, Descriptions and Specifications
 Table 158. Thrivous Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 159. Thrivous Recent Developments
 Table 160. Cymbiotika Corporation Information
 Table 161. Cymbiotika Description and Major Businesses
 Table 162. Cymbiotika Product Models, Descriptions and Specifications
 Table 163. Cymbiotika Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 164. Cymbiotika Recent Developments
 Table 165. Avior Nutritionals Corporation Information
 Table 166. Avior Nutritionals Description and Major Businesses
 Table 167. Avior Nutritionals Product Models, Descriptions and Specifications
 Table 168. Avior Nutritionals Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 169. Avior Nutritionals Recent Developments
 Table 170. Mibelle Biochemistry Corporation Information
 Table 171. Mibelle Biochemistry Description and Major Businesses
 Table 172. Mibelle Biochemistry Product Models, Descriptions and Specifications
 Table 173. Mibelle Biochemistry Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 174. Mibelle Biochemistry Recent Developments
 Table 175. Aramore Corporation Information
 Table 176. Aramore Description and Major Businesses
 Table 177. Aramore Product Models, Descriptions and Specifications
 Table 178. Aramore Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 179. Aramore Recent Developments
 Table 180. Codeage Corporation Information
 Table 181. Codeage Description and Major Businesses
 Table 182. Codeage Product Models, Descriptions and Specifications
 Table 183. Codeage Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 184. Codeage Recent Developments
 Table 185. PrimoNutra Corporation Information
 Table 186. PrimoNutra Description and Major Businesses
 Table 187. PrimoNutra Product Models, Descriptions and Specifications
 Table 188. PrimoNutra Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 189. PrimoNutra Recent Developments
 Table 190. Neurogan Health Corporation Information
 Table 191. Neurogan Health Description and Major Businesses
 Table 192. Neurogan Health Product Models, Descriptions and Specifications
 Table 193. Neurogan Health Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 194. Neurogan Health Recent Developments
 Table 195. NUNMN Corporation Information
 Table 196. NUNMN Description and Major Businesses
 Table 197. NUNMN Product Models, Descriptions and Specifications
 Table 198. NUNMN Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 199. NUNMN Recent Developments
 Table 200. Aurora Nutrascience Corporation Information
 Table 201. Aurora Nutrascience Description and Major Businesses
 Table 202. Aurora Nutrascience Product Models, Descriptions and Specifications
 Table 203. Aurora Nutrascience Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 204. Aurora Nutrascience Recent Developments
 Table 205. Nadia Skincare Corporation Information
 Table 206. Nadia Skincare Description and Major Businesses
 Table 207. Nadia Skincare Product Models, Descriptions and Specifications
 Table 208. Nadia Skincare Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 209. Nadia Skincare Recent Developments
 Table 210. IVY RX Corporation Information
 Table 211. IVY RX Description and Major Businesses
 Table 212. IVY RX Product Models, Descriptions and Specifications
 Table 213. IVY RX Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 214. IVY RX Recent Developments
 Table 215. Emrald Labs Corporation Information
 Table 216. Emrald Labs Description and Major Businesses
 Table 217. Emrald Labs Product Models, Descriptions and Specifications
 Table 218. Emrald Labs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 219. Emrald Labs Recent Developments
 Table 220. Key Raw Materials Distribution
 Table 221. Raw Materials Key Suppliers
 Table 222. Critical Raw Material Supplier Concentration (2024) & Risk Index
 Table 223. Milestones in Production Technology Evolution
 Table 224. Distributors List
 Table 225. Market Trends and Market Evolution
 Table 226. Market Drivers and Opportunities
 Table 227. Market Challenges, Risks, and Restraints
 Table 228. Research Programs/Design for This Report
 Table 229. Key Data Information from Secondary Sources
 Table 230. Key Data Information from Primary Sources


List of Figures
 Figure 1. NAD+ Anti-Aging Nutraceuticals Product Picture
 Figure 2. Global NAD+ Anti-Aging Nutraceuticals Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
 Figure 3. Capsules Product Picture
 Figure 4. Lozenges Product Picture
 Figure 5. Sprays Product Picture
 Figure 6. Others Product Picture
 Figure 7. Global NAD+ Anti-Aging Nutraceuticals Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
 Figure 8. Health Products
 Figure 9. Cosmetic
 Figure 10. Others
 Figure 11. NAD+ Anti-Aging Nutraceuticals Report Years Considered
 Figure 12. Global NAD+ Anti-Aging Nutraceuticals Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 13. Global NAD+ Anti-Aging Nutraceuticals Revenue (2020-2031) & (US$ Million)
 Figure 14. Global NAD+ Anti-Aging Nutraceuticals Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Figure 15. Global NAD+ Anti-Aging Nutraceuticals Revenue Market Share by Region (2020-2031)
 Figure 16. Global NAD+ Anti-Aging Nutraceuticals Sales (2020-2031) & (K Units)
 Figure 17. Global NAD+ Anti-Aging Nutraceuticals Sales (CAGR) by Region (2020-2031) (K Units)
 Figure 18. Global NAD+ Anti-Aging Nutraceuticals Sales Market Share by Region (2020-2031)
 Figure 19. Top 5 and Top 10 Manufacturers NAD+ Anti-Aging Nutraceuticals Sales Volume Market Share in 2024
 Figure 20. Global NAD+ Anti-Aging Nutraceuticals Revenue Market Share Ranking (2024)
 Figure 21. Tier Distribution by Revenue Contribution (2020 VS 2024)
 Figure 22. Capsules Revenue Market Share by Manufacturer in 2024
 Figure 23. Lozenges Revenue Market Share by Manufacturer in 2024
 Figure 24. Sprays Revenue Market Share by Manufacturer in 2024
 Figure 25. Others Revenue Market Share by Manufacturer in 2024
 Figure 26. Global NAD+ Anti-Aging Nutraceuticals Sales Market Share by Type (2020-2031)
 Figure 27. Global NAD+ Anti-Aging Nutraceuticals Revenue Market Share by Type (2020-2031)
 Figure 28. Global NAD+ Anti-Aging Nutraceuticals Sales Market Share by Application (2020-2031)
 Figure 29. Global NAD+ Anti-Aging Nutraceuticals Revenue Market Share by Application (2020-2031)
 Figure 30. North America NAD+ Anti-Aging Nutraceuticals Sales YoY (2020-2031) & (K Units)
 Figure 31. North America NAD+ Anti-Aging Nutraceuticals Revenue YoY (2020-2031) & (US$ Million)
 Figure 32. North America Top 5 Manufacturers NAD+ Anti-Aging Nutraceuticals Sales Revenue (US$ Million) in 2024
 Figure 33. North America NAD+ Anti-Aging Nutraceuticals Sales Volume (K Units) by Type (2020- 2031)
 Figure 34. North America NAD+ Anti-Aging Nutraceuticals Sales Revenue (US$ Million) by Type (2020 - 2031)
 Figure 35. North America NAD+ Anti-Aging Nutraceuticals Sales Volume (K Units) by Application (2020-2031)
 Figure 36. North America NAD+ Anti-Aging Nutraceuticals Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 37. US NAD+ Anti-Aging Nutraceuticals Revenue (2020-2031) & (US$ Million)
 Figure 38. Canada NAD+ Anti-Aging Nutraceuticals Revenue (2020-2031) & (US$ Million)
 Figure 39. Mexico NAD+ Anti-Aging Nutraceuticals Revenue (2020-2031) & (US$ Million)
 Figure 40. Europe NAD+ Anti-Aging Nutraceuticals Sales YoY (2020-2031) & (K Units)
 Figure 41. Europe NAD+ Anti-Aging Nutraceuticals Revenue YoY (2020-2031) & (US$ Million)
 Figure 42. Europe Top 5 Manufacturers NAD+ Anti-Aging Nutraceuticals Sales Revenue (US$ Million) in 2024
 Figure 43. Europe NAD+ Anti-Aging Nutraceuticals Sales Volume (K Units) by Type (2020-2031)
 Figure 44. Europe NAD+ Anti-Aging Nutraceuticals Sales Revenue (US$ Million) by Type (2020-2031)
 Figure 45. Europe NAD+ Anti-Aging Nutraceuticals Sales Volume (K Units) by Application (2020-2031)
 Figure 46. Europe NAD+ Anti-Aging Nutraceuticals Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 47. Germany NAD+ Anti-Aging Nutraceuticals Revenue (2020-2031) & (US$ Million)
 Figure 48. France NAD+ Anti-Aging Nutraceuticals Revenue (2020-2031) & (US$ Million)
 Figure 49. U.K. NAD+ Anti-Aging Nutraceuticals Revenue (2020-2031) & (US$ Million)
 Figure 50. Italy NAD+ Anti-Aging Nutraceuticals Revenue (2020-2031) & (US$ Million)
 Figure 51. Russia NAD+ Anti-Aging Nutraceuticals Revenue (2020-2031) & (US$ Million)
 Figure 52. Asia-Pacific NAD+ Anti-Aging Nutraceuticals Sales YoY (2020-2031) & (K Units)
 Figure 53. Asia-Pacific NAD+ Anti-Aging Nutraceuticals Revenue YoY (2020-2031) & (US$ Million)
 Figure 54. Asia-Pacific Top 8 Manufacturers NAD+ Anti-Aging Nutraceuticals Sales Revenue (US$ Million) in 2024
 Figure 55. Asia-Pacific NAD+ Anti-Aging Nutraceuticals Sales Volume (K Units) by Type (2020- 2031)
 Figure 56. Asia-Pacific NAD+ Anti-Aging Nutraceuticals Sales Revenue (US$ Million) by Type (2020- 2031)
 Figure 57. Asia-Pacific NAD+ Anti-Aging Nutraceuticals Sales Volume (K Units) by Application (2020-2031)
 Figure 58. Asia-Pacific NAD+ Anti-Aging Nutraceuticals Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 59. Indonesia NAD+ Anti-Aging Nutraceuticals Revenue (2020-2031) & (US$ Million)
 Figure 60. Japan NAD+ Anti-Aging Nutraceuticals Revenue (2020-2031) & (US$ Million)
 Figure 61. South Korea NAD+ Anti-Aging Nutraceuticals Revenue (2020-2031) & (US$ Million)
 Figure 62. China Taiwan NAD+ Anti-Aging Nutraceuticals Revenue (2020-2031) & (US$ Million)
 Figure 63. India NAD+ Anti-Aging Nutraceuticals Revenue (2020-2031) & (US$ Million)
 Figure 64. Central and South America NAD+ Anti-Aging Nutraceuticals Sales YoY (2020-2031) & (K Units)
 Figure 65. Central and South America NAD+ Anti-Aging Nutraceuticals Revenue YoY (2020-2031) & (US$ Million)
 Figure 66. Central and South America Top 5 Manufacturers NAD+ Anti-Aging Nutraceuticals Sales Revenue (US$ Million) in 2024
 Figure 67. Central and South America NAD+ Anti-Aging Nutraceuticals Sales Volume (K Units) by Type (2021-2031)
 Figure 68. Central and South America NAD+ Anti-Aging Nutraceuticals Sales Revenue (US$ Million) by Type (2020-2031)
 Figure 69. Central and South America NAD+ Anti-Aging Nutraceuticals Sales Volume (K Units) by Application (2020-2031)
 Figure 70. Central and South America NAD+ Anti-Aging Nutraceuticals Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 71. Brazil NAD+ Anti-Aging Nutraceuticals Revenue (2020-2025) & (US$ Million)
 Figure 72. Argentina NAD+ Anti-Aging Nutraceuticals Revenue (2020-2025) & (US$ Million)
 Figure 73. Middle East, and Africa NAD+ Anti-Aging Nutraceuticals Sales YoY (2020-2031) & (K Units)
 Figure 74. Middle East and Africa NAD+ Anti-Aging Nutraceuticals Revenue YoY (2020-2031) & (US$ Million)
 Figure 75. Middle East and Africa Top 5 Manufacturers NAD+ Anti-Aging Nutraceuticals Sales Revenue (US$ Million) in 2024
 Figure 76. Middle East and Africa NAD+ Anti-Aging Nutraceuticals Sales Volume (K Units) by Type (2021-2031)
 Figure 77. South America NAD+ Anti-Aging Nutraceuticals Sales Revenue (US$ Million) by Type (2020-2031)
 Figure 78. Middle East and Africa NAD+ Anti-Aging Nutraceuticals Sales Volume (K Units) by Application (2020-2031)
 Figure 79. Middle East and Africa NAD+ Anti-Aging Nutraceuticals Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 80. GCC Countries NAD+ Anti-Aging Nutraceuticals Revenue (2020-2025) & (US$ Million)
 Figure 81. Turkey NAD+ Anti-Aging Nutraceuticals Revenue (2020-2025) & (US$ Million)
 Figure 82. Egypt NAD+ Anti-Aging Nutraceuticals Revenue (2020-2025) & (US$ Million)
 Figure 83. South Africa NAD+ Anti-Aging Nutraceuticals Revenue (2020-2025) & (US$ Million)
 Figure 84. NAD+ Anti-Aging Nutraceuticals Industry Chain Mapping
 Figure 85. Regional NAD+ Anti-Aging Nutraceuticals Manufacturing Base Distribution (%)
 Figure 86. Global NAD+ Anti-Aging Nutraceuticals Production Market Share by Region (2020-2031)
 Figure 87. NAD+ Anti-Aging Nutraceuticals Production Process
 Figure 88. Regional NAD+ Anti-Aging Nutraceuticals Production Cost Structure
 Figure 89. Channels of Distribution (Direct Vs Distribution)
 Figure 90. Bottom-up and Top-down Approaches for This Report
 Figure 91. Data Triangulation
 Figure 92. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$4900

This license allows only one user to access the PDF.
Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Nano String

RELATED REPORTS

Global Organic Zinc Supplements Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-38U19850
Wed Dec 03 00:00:00 UTC 2025

Add to Cart

Global Egg Protein Hydrolysates Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-0Z20517
Wed Dec 03 00:00:00 UTC 2025

Add to Cart

Global PAC Flocculant Dosing Device Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-28R19905
Wed Dec 03 00:00:00 UTC 2025

Add to Cart

Global Polyaspartic Acid Magnesium Salt(PASP-Mg) Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-17G20275
Wed Dec 03 00:00:00 UTC 2025

Add to Cart